BELOTTI DANIELA

Pisani, I., Melita, G., de Souza, P., Galimberti, S., Savino, A., Sarno, J., et al. (2025). Optimized GMP-grade production of non-viral Sleeping Beauty-generated CARCIK cells for enhanced fitness and clinical scalability. JOURNAL OF TRANSLATIONAL MEDICINE, 23(1) [10.1186/s12967-025-06416-3]. Dettaglio

Lussana, F., Magnani, C., Galimberti, S., Gritti, G., Gaipa, G., Belotti, D., et al. (2025). Donor-derived CARCIK-CD19 cells engineered with Sleeping Beauty transposon in acute lymphoblastic leukemia relapsed after allogeneic transplantation. BLOOD CANCER JOURNAL, 15(1) [10.1038/s41408-025-01260-6]. Dettaglio

Buracchi, C., Belotti, D., Moretti, A., Calabretta, L., Risca, G., Capelli, C., et al. (2023). Deep immunophenotypic characterization of CARCIK-CD19 pre-infusion cellular product by advanced multiparametric flow cytometry. Intervento presentato a: ESLHO Symposium, Salamanca, Spain. Dettaglio

Zanier, E., Pischiutta, F., Rulli, E., Vargiolu, A., Elli, F., Gritti, P., et al. (2023). MesenchymAl stromal cells for Traumatic bRain Injury (MATRIx): a study protocol for a multicenter, double-blind, randomised, placebo-controlled phase II trial. INTENSIVE CARE MEDICINE EXPERIMENTAL, 11(1) [10.1186/s40635-023-00535-1]. Dettaglio

Genchi, A., Brambilla, E., Sangalli, F., Radaelli, M., Bacigaluppi, M., Furlan, R., et al. (2023). Neural stem cell transplantation in patients with progressive multiple sclerosis: an open-label, phase 1 study. NATURE MEDICINE, 29, 75-85 [10.1038/s41591-022-02097-3]. Dettaglio